{Etokimab: A Deep Analysis into the 2022981-44-6 Antibody Etokimab, designated by the unique identifier 2022981-44-6, represents a groundbreaking protein currently undergoing clinical evaluation. This biologic agent, https://www.targetmol.com/compound/etokimab